Skip to Main Content

An official website of the United States government

Here you can browse the complete list of projects on CDAS whose requests for data/biospecimens were approved.

Name Principal Investigator Institution Study Date Approved Project ID
Development of CAD for lung nodule screening Naïm Jalal GE HEALTHCARE NLST Oct 27, 2022 NLST-977
Alcohol Intake Across the Life Course and Risk of Ovarian Cancer in Postmenopausal Women Alexandra Schmidt University of North Dakota PLCO Oct 19, 2022 PLCO-1078
Survival analysis based on pathological images of lung cancer patients xiaofei xia Anhui University NLST Oct 19, 2022 NLST-976
Synthetic generation and tagging of CXR and pathology images Jonathan Pearson NHS Commissioning Board (NHS England) PLCO Oct 18, 2022 PLCOI-1077
Utilization of machine learning to create a predictive model for ovarian cancer based on pelvic ultrasound, CA-125, and clinical characteristics Graham Chapman Case Western Reserve University PLCO Oct 18, 2022 PLCO-1074
Global metabolomics profiling, dietary factors, and colorectal cancer risk in the NIHConsortium of Metabolomics Studies (COMETS) Jennifer Ose University of Utah PLCO Oct 18, 2022 PLCO-1067
Impact of Data Driven Decision Making in Healthcare Analytic May Myat University of Technology, Yatanarpon Cyber City(UTYCC), Pyin Oo Lwin, Myanmar PLCO Oct 18, 2022 PLCO-1064
Mathematical modelling of prostate cancer data Taylor deVet McMaster University PLCO Oct 18, 2022 PLCO-1073
Time Lag to Benefit: A Systematic Review and Meta-Analysis of Lung Cancer Screening Trials Alison Rustagi University of California, San Francisco NLST Oct 18, 2022 NLST-972
Machine Learning Analysis for Lung Cancer Progression Anderson Nnewihe Johnson & Johnson Enterprise Innovation, Inc. NLST Oct 18, 2022 NLST-973
Early diagnosis of lung cancer based on imbalance class data Xiaowen Yang Chongqing University of Posts and Telecommunications NLST Oct 18, 2022 NLST-967
Lung Nodule Malignancy Classification Based On Time-Series Model Chaoran Jia Dalian University of Technology NLST Oct 18, 2022 NLST-969
Risk-stratified multi-round PSA screening for prostate cancer incorporating population-based screening reference level and subgroup-specific progression indicators Huang Yubei Tianjin Medical University Cancer Institute and Hospital PLCO Oct 11, 2022 PLCO-1072
Causal inference with incomplete compliance or outcomes truncated by death Aixian Chen School of Economics and Statistics, Guangzhou University, Guangzhou, China PLCO Oct 11, 2022 PLCO-1069
Integrating multi-omics information to explore disease processes Tiantian Sun Shandong University PLCO Oct 11, 2022 PLCO-1060
Looking for the retrospective link between cigarette habits in men and prostate cancer Tamara yaghi American international School of riyadh PLCO Oct 11, 2022 PLCO-1071
The association of the sulfur microbial diet with colorectal adenoma and recurrent adenoma risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Linglong Peng The Second Affiliated Hospital of Chongqing Medical University PLCO Oct 11, 2022 PLCO-1070
PREDICTED MORTALITY AS A SURROGATE ENDPOINT IN THE PLCO TRIAL Matejka Rebolj Queen Mary University of London PLCO Oct 11, 2022 PLCO-1066
Comparative analysis of the cost-effectiveness and implementation of lung cancer screening with LDCT in the US and EU Tanya Rajabi Semmelweis University NLST Oct 11, 2022 NLST-968
Lung cancer risk assessment Adam Vasserstrom Nucleix NLST Oct 11, 2022 NLST-965